Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin : ODYSSEY NIPPON study design and rationale
- Publication date
- 30 November 2020
- Publisher
- BioMed Central|Springer Nature